Asparkam Table 56 pcs renewal

Description

Composition
Active substance:
1 tablet contains: potassium aspartate – 0.175 g Magnesium aspartate – 0.175 g ,.
Excipients:
Calcium octadecanoate (calcium stearate), potato or corn starch, talc.
Description:
Tablets of white color, Valium with a facet and Valium.
Product form:
10 tablets in contour bezgyachakova packing. 10 tablets in blisters. 50 tablets in glass jars or plastic jars. Each jar or 2, contour packs 5 together with instructions for use placed in a pile of cardboard.
Contraindications
Increased sensitivity to the drug, impaired metabolism of amino acids, hypotension, acute and chronic renal failure, hyperkalemia, gipermagniemiya, impaired atrioventricular conduction (AV I-III degree), myasthenia gravis, acute metabolic acidosis, dehydration (exsicosis), hemolysis, Addison’s disease.
Precautions prescribed during pregnancy (especially I trimester) and lactation.
Dosage
177mg + 177mg
Indications
Asparkam used in the treatment of heart failure, coronary heart disease, hypokalemia, cardiac arrhythmias (including myocardial infarction, an overdose of cardiac glycosides).
Interaction with other drugs
Pharmacodynamic: combined use of potassium-sparing diuretics (triamterene, spironolactone), beta-blockers, cyclosporine, heparin, ACE inhibitors, nonsteroidal antiinflammatory drugs increases the risk of hyperkalemia until the development of arrhythmias and asystole. The use of drugs in conjunction with potassium glucocorticosteroids eliminates hypokalemia caused by the latter. Under the influence of potassium decreases the unwanted effects of cardiac glycosides. Magnesium reduces the effect of neomycin, polymyxin B, tetracycline and streptomycin. Anesthetics increase inhibitory effect on the CNS drugs magnesium; while the use of atrakuroniem, decamethonium, succinyl and suxamethonium may increase neuromuscular blockade; calcitriol increases the magnesium content in blood plasma, calcium supplementation reduces the effect of magnesium preparations. Enhances negative Drome and batmotroponoe effects of antiarrhythmic drugs.
Pharmacokinetic: knitting and enveloping means reduce the absorption of the drug in the gastrointestinal tract.
Overdose
Symptoms: conduction disturbances (especially in previous pathology of cardiac conduction system).
pharmachologic effect
Pharmacological group:
Potassium and magnesium preparation.
Pharmacodynamics:
Asparkam a source of potassium and magnesium ions, regulates metabolic processes. The mechanism of action presumably associated with a role as a carrier asparaginata magnesium and potassium ions into the intracellular space and asparaginate participation in metabolic processes. Thus asparkam eliminates electrolyte imbalance, decreases myocardial excitability and conductivity (moderate antiarrhythmic effect).
Pharmacokinetics:
Easily absorbed when taken orally and relatively rapidly excreted by the kidneys.
Conditions of supply of pharmacies
Without recipe.
side effects
Nausea, vomiting, diarrhea, discomfort or burning epigastric (anatsidnyh patients with gastritis or cholecystitis), ulceration of the gastrointestinal mucosa, bleeding from the intestine, flatulence, dry mouth; bradycardia, itching, dizziness; myasthenia gravis, asthenia, sweating; atrioventricular block, paradoxical response (increase in the number of extrasystoles), hyperkalemia (nausea, vomiting, diarrhea, paresthesias) gipermagniemiya (facial flushing, thirst, lowering blood pressure, hyporeflexia, respiratory depression, convulsions).
Storage conditions
Stored in a dry place at a temperature not higher than 20 ° C.
Keep out of the reach of children.
Dosing and Administration
Asparkam administered orally after meals.
Usually prescribed for adults 1-2 tablets 3 times a day. The course of treatment – 3-4 weeks. repeat the course if necessary.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist